Log In
Print
BCIQ
Print
Print this Print this
 

Reditux, Biosimilar rituximab

  Manage Alerts
Collapse Summary General Information
Company Dr. Reddy's Laboratories Ltd.
DescriptionRituximab biosimilar
Molecular Target CD20
Mechanism of Action 
Latest Stage of DevelopmentMarketed
IndicationNon-Hodgkin's lymphoma (NHL)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today